Repligen Cost of Revenue vs Accounts Payable Analysis

RGEN Stock

USD 157.06 3.92 2.44%

Repligen financial indicator trend analysis is much more than just breaking down Repligen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Repligen is a good investment. Please check the relationship between Repligen Cost Of Revenue and its Accounts Payable accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Cost Of Revenue vs Accounts Payable

Cost of Revenue vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Repligen Cost of Revenue account and Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Repligen's Cost of Revenue and Accounts Payable is -0.05. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Repligen, assuming nothing else is changed. The correlation between historical values of Repligen's Cost of Revenue and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of Repligen are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Cost of Revenue i.e., Repligen's Cost of Revenue and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.05

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Repligen income statement and represents the costs associated with goods and services Repligen provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Accounts Payable

An accounting item on the balance sheet that represents Repligen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Repligen are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Repligen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Selling General Administrative is very stable compared to the past year. As of the 19th of April 2024, Enterprise Value Over EBITDA is likely to grow to 79.75, while Tax Provision is likely to drop about 7.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	391.3M	455.7M	284.2M	538.9M
Total Revenue	670.5M	801.5M	638.8M	768.0M

Gross Profit Total Revenue

Repligen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Term Debt	Other Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.94	0.96	0.78	0.81	0.95	-0.38	0.93	0.96	0.97	0.11	0.97	0.97	0.61	0.82	0.96	0.94	0.66	0.97	0.94	0.99	0.86	0.49	0.36	0.78	0.12
Short Long Term Debt Total	0.94		0.87	0.57	0.89	0.95	-0.13	0.94	0.89	0.93	0.1	0.89	0.93	0.49	0.95	0.9	0.98	0.77	0.97	0.95	0.92	0.72	0.27	0.28	0.66	0.01
Other Current Liab	0.96	0.87		0.87	0.76	0.94	-0.38	0.9	0.9	0.96	0.14	0.93	0.98	0.71	0.73	0.98	0.87	0.64	0.94	0.92	0.96	0.94	0.64	0.25	0.81	0.25
Total Current Liabilities	0.78	0.57	0.87		0.48	0.72	-0.57	0.68	0.74	0.79	0.04	0.78	0.82	0.72	0.33	0.82	0.64	0.34	0.7	0.68	0.8	0.91	0.87	0.16	0.75	0.34
Total Stockholder Equity	0.81	0.89	0.76	0.48		0.85	0.01	0.83	0.73	0.82	0.11	0.72	0.85	0.33	0.86	0.81	0.92	0.94	0.87	0.88	0.77	0.71	0.23	0.27	0.5	-0.18
Property Plant And Equipment Net	0.95	0.95	0.94	0.72	0.85		-0.11	0.98	0.85	0.96	0.11	0.87	0.97	0.53	0.85	0.99	0.95	0.71	0.97	1.0	0.93	0.83	0.45	0.27	0.69	0.24
Net Debt	-0.38	-0.13	-0.38	-0.57	0.01	-0.11		-0.08	-0.56	-0.33	0.04	-0.54	-0.3	-0.59	0.02	-0.22	-0.15	0.06	-0.24	-0.06	-0.46	-0.44	-0.48	-0.12	-0.58	0.18
Retained Earnings	0.93	0.94	0.9	0.68	0.83	0.98	-0.08		0.84	0.94	0.16	0.86	0.95	0.45	0.86	0.96	0.95	0.69	0.96	0.98	0.91	0.77	0.38	0.22	0.66	0.22
Cash	0.96	0.89	0.9	0.74	0.73	0.85	-0.56	0.84		0.94	0.13	1.0	0.92	0.66	0.79	0.86	0.88	0.62	0.94	0.83	0.98	0.81	0.43	0.23	0.84	-0.07
Non Current Assets Total	0.97	0.93	0.96	0.79	0.82	0.96	-0.33	0.94	0.94		0.2	0.96	0.99	0.64	0.84	0.97	0.93	0.7	0.99	0.94	0.98	0.88	0.48	0.14	0.82	0.08
Non Currrent Assets Other	0.11	0.1	0.14	0.04	0.11	0.11	0.04	0.16	0.13	0.2		0.13	0.15	0.01	0.2	0.14	0.11	0.22	0.17	0.11	0.14	0.1	-0.02	-0.33	0.18	-0.17
Cash And Short Term Investments	0.97	0.89	0.93	0.78	0.72	0.87	-0.54	0.86	1.0	0.96	0.13		0.94	0.68	0.78	0.89	0.88	0.59	0.94	0.85	0.99	0.82	0.47	0.25	0.84	0.01
Net Receivables	0.97	0.93	0.98	0.82	0.85	0.97	-0.3	0.95	0.92	0.99	0.15	0.94		0.65	0.81	0.98	0.94	0.73	0.98	0.96	0.97	0.91	0.55	0.2	0.79	0.13
Common Stock Shares Outstanding	0.61	0.49	0.71	0.72	0.33	0.53	-0.59	0.45	0.66	0.64	0.01	0.68	0.65		0.33	0.62	0.45	0.27	0.57	0.49	0.68	0.73	0.63	-0.05	0.89	0.16
Non Current Liabilities Total	0.82	0.95	0.73	0.33	0.86	0.85	0.02	0.86	0.79	0.84	0.2	0.78	0.81	0.33		0.78	0.9	0.81	0.91	0.87	0.8	0.55	-0.01	0.19	0.55	-0.15
Inventory	0.96	0.9	0.98	0.82	0.81	0.99	-0.22	0.96	0.86	0.97	0.14	0.89	0.98	0.62	0.78		0.92	0.67	0.96	0.97	0.94	0.9	0.58	0.22	0.75	0.29
Other Current Assets	0.94	0.98	0.87	0.64	0.92	0.95	-0.15	0.95	0.88	0.93	0.11	0.88	0.94	0.45	0.9	0.92		0.8	0.97	0.96	0.92	0.75	0.36	0.27	0.65	-0.01
Other Stockholder Equity	0.66	0.77	0.64	0.34	0.94	0.71	0.06	0.69	0.62	0.7	0.22	0.59	0.73	0.27	0.81	0.67	0.8		0.76	0.74	0.64	0.6	0.14	0.09	0.42	-0.32
Total Liab	0.97	0.97	0.94	0.7	0.87	0.97	-0.24	0.96	0.94	0.99	0.17	0.94	0.98	0.57	0.91	0.96	0.97	0.76		0.96	0.97	0.83	0.38	0.22	0.76	0.04
Property Plant And Equipment Gross	0.94	0.95	0.92	0.68	0.88	1.0	-0.06	0.98	0.83	0.94	0.11	0.85	0.96	0.49	0.87	0.97	0.96	0.74	0.96		0.9	0.81	0.42	0.27	0.66	0.22
Total Current Assets	0.99	0.92	0.96	0.8	0.77	0.93	-0.46	0.91	0.98	0.98	0.14	0.99	0.97	0.68	0.8	0.94	0.92	0.64	0.97	0.9		0.87	0.51	0.24	0.84	0.07
Accounts Payable	0.86	0.72	0.94	0.91	0.71	0.83	-0.44	0.77	0.81	0.88	0.1	0.82	0.91	0.73	0.55	0.9	0.75	0.6	0.83	0.81	0.87		0.72	0.17	0.78	0.18
Short Term Debt	0.49	0.27	0.64	0.87	0.23	0.45	-0.48	0.38	0.43	0.48	-0.02	0.47	0.55	0.63	-0.01	0.58	0.36	0.14	0.38	0.42	0.51	0.72		0.11	0.5	0.47
Other Assets	0.36	0.28	0.25	0.16	0.27	0.27	-0.12	0.22	0.23	0.14	-0.33	0.25	0.2	-0.05	0.19	0.22	0.27	0.09	0.22	0.27	0.24	0.17	0.11		-0.01	0.2
Common Stock Total Equity	0.78	0.66	0.81	0.75	0.5	0.69	-0.58	0.66	0.84	0.82	0.18	0.84	0.79	0.89	0.55	0.75	0.65	0.42	0.76	0.66	0.84	0.78	0.5	-0.01		0.05
Short Term Investments	0.12	0.01	0.25	0.34	-0.18	0.24	0.18	0.22	-0.07	0.08	-0.17	0.01	0.13	0.16	-0.15	0.29	-0.01	-0.32	0.04	0.22	0.07	0.18	0.47	0.2	0.05

Click cells to compare fundamentals

Repligen Account Relationship Matchups

Repligen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.4B	1.9B	2.4B	2.5B	2.8B	3.0B
Short Long Term Debt Total	263.3M	275.4M	366.1M	423.0M	711.8M	747.4M
Other Current Liab	28.3M	37.8M	60.7M	65.8M	53.2M	55.9M
Total Current Liabilities	48.3M	319.0M	375.3M	404.2M	158.2M	166.1M
Total Stockholder Equity	5.8M	65.8M	1.8B	397.3M	2.0B	2.1B
Property Plant And Equipment Net	74.2M	92.0M	226.5M	315.7M	323.0M	339.1M
Net Debt	(265.1M)	(441.9M)	(237.8M)	(100.5M)	(39.5M)	(41.5M)
Retained Earnings	5.8M	65.8M	194.1M	397.3M	438.8M	460.8M
Cash	528.4M	717.3M	603.8M	523.5M	751.3M	788.9M
Non Current Assets Total	758.3M	1.0B	1.4B	1.5B	1.7B	1.8B
Non Currrent Assets Other	238K	573K	615K	815K	1.3M	1.3M
Cash And Short Term Investments	528.4M	717.3M	603.8M	623.8M	751.3M	788.9M
Net Receivables	43.7M	71.4M	117.4M	116.2M	124.2M	130.4M
Common Stock Shares Outstanding	49.2M	53.9M	57.3M	57.5M	56.4M	29.9M
Liabilities And Stockholders Equity	346.2M	439.5M	2.4B	1.0B	2.8B	3.0B
Non Current Liabilities Total	292.0M	54.8M	233.0M	209.8M	695.0M	729.8M
Inventory	54.8M	95.0M	184.5M	238.3M	202.3M	212.4M
Other Current Assets	3.1M	14.1M	19.3M	17.4M	33.2M	34.9M
Other Stockholder Equity	14.5M	(2.6M)	1.6B	33.8M	1.6B	1.6B
Total Liab	340.3M	373.7M	608.3M	614.0M	853.2M	895.9M
Property Plant And Equipment Gross	74.2M	92.0M	297.2M	408.0M	451.7M	474.3M
Total Current Assets	641.8M	902.4M	931.7M	998.1M	1.1B	1.2B
Accumulated Other Comprehensive Income	(15.0M)	2.1M	(16.9M)	(34.4M)	(37.4M)	(35.6M)
Accounts Payable	11.4M	16.9M	36.2M	27.6M	19.6M	20.5M
Short Term Debt	3.6M	249.0M	263.6M	291.6M	75.1M	101.1M
Other Assets	3.2M	28.2M	2.5M	1.7M	1.5M	1.6M
Common Stock Total Equity	521K	548K	553K	556K	639.4K	389.2K
Common Stock	521K	548K	553K	556K	558K	398.5K
Property Plant Equipment	48.5M	66.9M	125.0M	190.7M	219.3M	230.2M
Other Liab	32.3M	28.4M	130.5M	78.4M	90.1M	94.6M
Current Deferred Revenue	5.0M	15.3M	14.8M	19.3M	10.3M	5.4M
Good Will	468.4M	618.3M	860.4M	855.5M	987.1M	1.0B
Intangible Assets	212.6M	287.1M	337.3M	353.7M	400.5M	420.5M
Net Tangible Assets	378.8M	623.7M	552.4M	701.5M	806.7M	847.1M
Retained Earnings Total Equity	5.8M	65.8M	194.1M	397.3M	456.9M	479.7M
Capital Surpluse	1.1B	1.5B	1.6B	1.5B	1.8B	1.9B

Currently Active Assets on Macroaxis

BAC	Bank of America
DD	Dupont De Nemours
F	Ford Motor
WD	Walker Dunlop
GOOG	Alphabet Inc Class C

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Repligen Stock analysis

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Transaction History View history of all your transactions and understand their impact on performance
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum

Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.55)

Earnings Share

0.74

Revenue Per Share

11.464

Quarterly Revenue Growth

(0.17)

Return On Assets

0.0131

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repligen Cost of Revenue vs Accounts Payable Analysis

Cost Of Revenue vs Accounts Payable

Cost of Revenue vs Accounts Payable Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Accounts Payable

Repligen fundamental ratios Correlations

Repligen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Repligen fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Repligen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Inventory	+ 0.99	Property Plant And Equipment Net
Net Receivables	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Assets Total

Common Stock Shares Outstanding	- 0.59	Net Debt
Common Stock Total Equity	- 0.58	Net Debt
Net Debt	- 0.57	Total Current Liabilities
Cash	- 0.56	Net Debt
Cash And Short Term Investments	- 0.54	Net Debt
Short Term Debt	- 0.48	Net Debt